Cottontail rabbit papillomavirus (CRPV)-induced papillomas progress at a high frequency to carcinomas and thus can serve as a model for high-cancer-risk human papillomavirus infection. Previously, we have shown that antibodies to nonstructural and structural proteins are detected in only a fraction of papilloma-bearing animals. However, the antibody response to structural proteins drastically increases as papillomas progress to carcinoma (Y.-L. Lin, L. A. Borenstein, R. Selvakumar, R. Ahmed, and F. 0. Wettstein, J. Virol. 67:382-389, 1993). Here we have monitored the cellular immune response to viral proteins during the course of infection and particularly during progression from papilloma to carcinoma. This was done by measuring the in vitro proliferation response of peripheral blood mononuclear cells (PBMCs) to CRPV structural proteins LI and L2. The proliferating cells were identified as T cells by selective removal of B or T cells. In general, the T-cell response was low for rabbits at the papilloma stage and none responded to L2. Lymphocytes from animals with carcinomas more frequently and more strongly responded to Li, and more than half also responded to L2. In addition to stimulation of PBMCs, Li-and L2-specific proliferation could also be demonstrated with lymph node and spleen cells. Overall, our data show that progression of papilloma to carcinoma is associated with an increased T-cell response to CRPV structural proteins in addition to an increased humoral response. This greater immune reactivity, however, was not associated with a selectively increased expression of structural proteins, since RNA isolated from papillomas and carcinomas contained similar relative levels of late and early RNA as shown by dot blot analysis. Thus, the heightened immune reactivity seen in carcinoma-bearing rabbits most likely reflects greater stimulation of the immune system owing to dissemination of the tumor. These findings suggest that increased immune responses to papillomavirus proteins may be prognostic of progression to carcinoma and particularly of the development of metastases.
Papillomaviruses are small DNA viruses with a circular double-stranded DNA of about 8 kb. The viruses are highly species specific, and viral replication is confined to the epithelium and linked to the differentiation of epithelial keratinocytes (21) . Most papillomavirus infections result only in local lesions characterized by growth stimulation of the infected epithelium, leading to the formation of papillomas or warts. Papillomas can persist for a very long time, often the lifetime of the host, and this suggests that these viruses can evade host defense mechanisms effective against other viruses. The spontaneous regression of papillomas and the increased development of papillomavirus-induced lesions in immunosuppressed hosts (8) , however, suggest that the immune system can affect the host-virus interaction. A major interest in papillomaviruses derives from the fact that lesions induced by some of the viruses progress to carcinoma. Thus, certain genital human papillomaviruses (HPVs), such as HPV type 16 (HPV16), HPV18, and others (25) , play an essential role in the development of anogenital cancer, and some cutaneous HPVs, e.g., HPV5 and HPV8, are associated with skin cancers in patients with the relatively rare disease epidermodysplasia verruciformis (12) .
The first papillomavirus isolated was the cottontail rabbit papillomavirus (CRPV) (15) , and it is also the first papillomavirus for which a connection between papillomavirus infection and cancer was clearly established (14) . In the natural cottontail rabbit host, about 25% of infected animals develop cancers. Domestic rabbits are equally susceptible to viral infection, but produce little if any virus. However, papillomas on more than two-thirds of the animals progress to cancers (20) . In both species, a portion of the infected animals have papillomas that spontaneously regress; regression in domestic rabbits was shown to be linked to a major histocompatibility complex class II allotype (3) . Furthermore, in animals with regressing papillomas there was increased leukocyte infiltration in the dermis and most of the cells were T cells (10, 11) . Previously, we analyzed the humoral immune response to CRPV proteins in virus-infected rabbits (6) . At the papilloma stage, less than a third of the animals were positive for any of the viral proteins, using Western immunoblots, and none reacted with E4, E5, and L2. After progression to carcinoma, there was a drastic increase in the frequency and intensity of the response to the two viral structural proteins Li and L2. In this investigation we have examined the T-cell response to the two viral structural proteins in animals with papillomas and carcinomas.
In vitro proliferation assay for rabbit PBMCs. To further explore the basis for the change in the immune response to structural proteins during progression, the cellular immune response to these proteins was evaluated. This was accomplished by developing an in vitro proliferation assay for rabbit peripheral blood mononuclear cells (PBMCs). Two carcinomabearing rabbits were [3H]thymidine incorporated in response to trpE was considerrnse to L2, as ably lower than that in response to the fusion proteins but still previously (6) .
was higher than that incorporated into cells incubated in the obtained from presence of medium only, which was usually around 100 cpm bes. The blood (data not shown). As can be seen, the incorporation into (PBS), layered
PBMCs from an uninfected animal cultured in the presence of igma Chemical trpE or trpE-Ll was not significantly different at any time point in an IEC 210 (Fig. 1A ). To provide a numerical value for the specific ed and washed stimulation, a stimulation index (SI) was calculated, which ential medium.
represents the ratio of the highest amount of [3H]thymidine r than 95% as incorporated in wells containing topE-L1 or trpE-L2 divided by concentration that incorporated into wells with trpE measured on the same ulture medium day. On day 6, the SI for Li (Fig. 1A ) was 5.3, and that for L2 ented with 1% ( To further strengthen this conclusion, the effect of B-cell removal on antigen-stimulated proliferation was evaluated. B cells were removed by binding to anti-rabbit immunoglobulin G (IgG)-coated petri dishes. Petri dishes (100-mm diameter) were coated with 50 ,ug of affinity-purified goat anti-rabbit IgG (Cappel Laboratories). Purified PBMCs (1 x 107 to 2 x 107) were added to coated or uncoated petri dishes and incubated at 4°C for 2 h. Nonadherent cells were recovered by gentle washing with serum-free RPMI 1640 medium and stimulated in a standard proliferation assay with 100 ng of goat anti-rabbit IgG, 60 ng of trpE-Ll, or 60 ng of trpE per well (Fig. 2B) . The effective removal of B cells by binding to anti-rabbit IgGcoated petri dishes is demonstrated by the great reduction in [3H]thymidine incorporation in response to stimulation with anti-rabbit IgG. The depletion of B cells was also confirmed by fluorescence-activated cell sorter analysis (data not shown). The trpE-Li-stimulated [3H]thymidine incorporation, however, is higher in the T-cell-enriched nonadherent cells than in control cells, whereas trpE-stimulated incorporation is low with both. Overall, these data demonstrate that T cells specifically responded to Li.
Proliferation response to Li and L2 during progression to carcinoma. To determine whether an increased recognition of viral structural proteins with tumor progression was also a feature of the cellular immune system, PBMCs from papilloma-and carcinoma-bearing animals were tested for their in vitro proliferation response to trpE-Ll and trpE-L2 and to trpE. The SIs were calculated as described above to provide a measure for the specific response to Li and L2. The values shown in Fig. 3 are the highest ones for each rabbit and tumor stage. SIs greater than two were considered positive. Seventeen rabbits with papillomas were tested for their responses to Li and L2. Eight rabbits had a positive response to Li (SI > 2), but the majority of the responses were low (Fig. 3A, left) , whereas no animal had a positive response to L2 (Fig. 3B, left) . Twelve rabbits were evaluated at the carcinoma stage; 10 rabbits were tested for both antigens, and 1 each was tested for
Li or L2 only. Nine of the 11 rabbits had a positive response to Li, and in the majority the responses were medium to high (Fig. 3A, right) . In contrast to the absence of a response to L2 at the papilloma stage, 7 of 11 carcinoma-bearing animals responded positively to L2 (Fig. 3B, right) . In animals for which both antigens were evaluated, the response to Li in general was higher. In addition to PBMCs, the cellular immune response to the structural proteins was also measured in spleen and lymph node cells (Table 1) Proliferation and antibody response to viral structural proteins. The development of the proliferation response to viral structural proteins was monitored in two animals over a period of several months (Fig. 4) . In one animal (Fig. 4A) Northern (RNA) blots (9, 13, 23). The increase in both antibody and proliferation response long after infection suggests that these antigens continue to be synthesized and their synthesis may be higher in carcinomas. To determine whether the level of late mRNA in carcinomas was specifically increased relative to early mRNA, dot blots were prepared. Poly(A)+ RNA was isolated from papilloma and carcinoma tissues and treated with RNase-free DNase, and duplicate dot blots were prepared as described previously (7) . One blot was hybridized with a probe that contained open reading frame Li which hybridizes with Li as well as with L2 mRNA (9) ( Presence of transcripts for structural proteins in papillomas and carcinomas. Two identical dot blots were prepared and hybridized, as previously described (7). (A) The filter was hybridized with a probe specific for Li and L2 transcripts (0.5 x 106 cpm/ml) and exposed for 7 days. (B) The filter was hybridized with a genomic probe (2 x 106 cpm/ml) and exposed for 18 h. The horizontal rows A and B contained the same amount of poly(A)+ RNA for each sample; the RNA in row A was treated with NaOH. The following amounts of RNA were applied: rows A and B, 4, 4, 2, 4, 2, 8, and 1 jig, respectively; row C, 1, 1, 1, 1, 0.6, 1, and 0 jig, respectively; row D, 0.5, 0.5, 0.5, 0, 0.5, and 0 jug, respectively. The RNAs in vertical rows 1, 2, and 4 were from papillomas; those in rows 3, 5, and 6 were from carcinomas; and RNA in row 7 was from a CRPV-negative rabbit epithelial cell line. 5A), and one blot was hybridized with a full genomic CRPV probe (Fig. 5B) . Dots in rows A and B of each RNA preparation contained the same amount of RNA. The RNAs spotted in row A, however, were treated with NaOH before being spotted onto the filter. Rows C and D contained decreasing amounts of RNA. Papilloma RNA was present in rows 1, 2, and 4, and carcinoma RNA was in rows 3, 5, and 6; row 7 contained RNA from a CRPV DNA-negative rabbit epithelial cell line. The absence of spots in rows A showed that the RNA was not contaminated with any DNA. Control dot blots with NaOH or formamide-denatured viral DNA showed strong hybridization with both probes (data not shown). Although there is a considerable variation in the content of viral RNA, the relative intensity of corresponding spots between Fig. 5A and B is similar. This indicated that there was no major difference in late relative to early gene transcription between papillomas and carcinomas. The dot blot data thus suggest that the increased cellular and humoral immune responses to Li and L2 were not related to a selective increase in the level of late gene expression.
In the analyses performed here, the cellular immune responses to viral structural proteins in papilloma-and carcinoma-bearing rabbits were determined. This was of particular interest since the investigation of the humoral response (6) showed a major change during tumor progression in the response to these proteins but not to others. First, it was demonstrated that selective removal of T cells from PBMCs abolished the response to Li, whereas removal of B cells increased the response. This demonstrated that T cells specifically responded to Li. Comparison of the T-cell responses to Li between papilloma-and carcinoma-bearing rabbits showed an increase of from 47 to 82% with tumor progression. The previously reported increase in the humoral response to Li was from 29 to 91% (6) . With L2, the difference between the stages was more dramatic as no animals at all responded to L2 at the papilloma stage while 58% were positive at the carci-noma stage. These differences are very similar to those observed with the antibody response for which the change was from 0 to 50% (6) . Thus, both the cellular and humoral immune responses increased with tumor progression.
One possible reason for the progression-associated increase in immune response to structural but not to nonstructural proteins was a selective increase in the expression of structural viral genes. Since the characteristic transcripts of 4.8 and 2.6 kb have not been detected in Northern blots of RNA isolated from domestic rabbit tumors, dot blot hybridizations were performed. A genomic probe gave strong signals with most tumors because of its hybridization to the E6-and E7-encoding transcripts of 2.0 and 1.3 kb, representing the major transcripts in domestic rabbit tumors. The hybridization with the structural gene probe specific for LI and L2 mRNA was much weaker and also variable. The relative intensity of hybridization with the two probes, however, was similar for papilloma and carcinoma tissues and this suggested that there was no increase in the expression of late relative to early genes as a papilloma progressed to carcinoma. The variation observed with both types of transcripts could be a consequence of the greatly variable viral DNA content in both papilloma and carcinoma cells, which ranges from about 10 to a few hundred viral gene copies per diploid cell DNA equivalent (18, 19, 22) . Some variation, although minor, may reflect a contamination of tumor tissue with normal tissue or infiltration of tumors with immune cells.
A general increase in the immune response to viral protein during tumor progression could be explained by a more extensive interaction between virus-infected cells and the immune system at the carcinoma stage, particularly when metastases develop. However, this could not explain why the increased response is specific for the structural proteins. A possible explanation could come from in situ hybridizations. In domestic rabbit papillomas, expression of structural genes was confined to the uppermost layer of the epithelium while in carcinomas, structural genes could be detected throughout the entire tumor tissue (24) . Thus, the development of carcinomas or metastases may be particularly beneficial to the immune recognition of structural proteins but may have less of an effect on the recognition of nonstructural proteins which are expressed predominantly in the lower level of the epithelium in papillomas. The finding that the immune response to the minor structural protein, L2, is almost as high as that to the major structural protein, LI, may indicate that the former is a more potent antigen. This is suggested by the finding that immunization with trpE-L2 elicits a stronger antibody response than immunization with trpE-LI (5) .
Information about the immune response with progression of tumors induced by other papillomaviruses is limited. However, available evidence suggests that changes with progression do occur with the other high-cancer-risk papillomaviruses (25) . Thus, in cancer patients there was an increased response to E7 of HPV16 (4) and HPV18 (1), while a response to the late proteins was more frequently detected in patients with benign lesions associated with virus production (4). However, no differences were detected in the lymphoproliferation responses to HPV16 E4 and E6 or to HPV18 E6 between patients with HPV lesions (cervical intraepithelial neoplasias) and controls (2) . In contrast, a positive lymphoproliferation response to virions or E4 was observed in individuals infected with, or with a history of infection with, the low-cancer-risk HPV1 (16) . Similar to the situation with CRPV, an increased antibody response to LI of HPV8, a high-cancer-risk cutaneous HPV, was observed in patients with squamous cell carcinoma compared with uninfected controls (17) . Thus, changes in the immune response with progression of tumors associated with high-cancer-risk papillomaviruses may be a general feature and prognostic for cancer development. Here we have shown in an experimental system that progression of tumors induced by a high-cancer-risk papillomavirus indeed is associated with an increased T-cell response to specific viral proteins.
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